Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06406855 · ClinicalTrials.gov registry record · NA

Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)

A NA study of Spinal Cord Injuries, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT06406855 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by University of Miami. The registered enrollment target is 12 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06406855, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to test the effectiveness of a new therapy, called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS), for improving walking in people with an incomplete spinal cord injury (SCI).

Conditions Studied

Interventions

  • OTHER BCI-TSCS

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-05-07
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06406855

The ClinicalTrials.gov registry entry for NCT06406855 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (81% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which BCI-TSCS is the first listed.

NCT06406855 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06406855 about?

NCT06406855 is a clinical study titled "Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)". The purpose of this research is to test the effectiveness of a new therapy, called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS), for improving walking in people with an incomplete spinal cord injury (SCI).

What is the current status of trial NCT06406855?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-05-07. Estimated completion is 2026-12-31.

What conditions does trial NCT06406855 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT06406855?

The interventions under investigation include: BCI-TSCS (OTHER).

Who is sponsoring clinical trial NCT06406855?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06406855 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.